Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
about
T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124)Toxin-based targeted therapy for malignant brain tumorsCharacterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptideGenetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Clinical needs for hematopoietic growth factors: old and new.Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo.Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot studyKinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.Interleukin-4 and interleukin-13: their similarities and discrepancies.Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer ratsInduction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.STAT6 mediates interleukin-4 growth inhibition in human breast cancer cellsInterleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.Inhibition of angiogenesis by interleukin 4.Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesionIL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion proteinInterleukin-4 receptor-targeted liposomal doxorubicin as a model for enhancing cellular uptake and antitumor efficacy in murine colorectal cancer.Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.PTP1B is a negative regulator of interleukin 4-induced STAT6 signalingInterleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK.Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer TherapyChallenges in clinical design of immunotherapy trials for malignant glioma.Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.Interleukin-4 and cancer therapy.Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution.Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor.Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by MAb MR6 and IL-4.Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptorsGrowth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.
P2860
Q24338883-0CAF2432-1AC8-4C44-943C-0D1F4005BA7BQ24680021-7E566519-D417-4103-95D4-D669A57FECD4Q27006226-2FE625C1-B1C2-4CB7-96AC-ACEE9C716540Q28208081-512CC398-BE2A-40A5-8378-E7C96B4D4108Q28536690-444D9A9A-53E6-4C23-9C63-5502D41AC09EQ30504100-369DF6B4-3A49-4E77-A6E9-44D119341CE4Q33497903-3A1E5DBC-98A8-40BD-B449-A8D5D406F3F1Q33605925-1B133A01-371B-4D37-98D2-07663FD9F312Q33624331-8BFFEAC9-06B3-4920-8990-2057428B39B8Q33657635-7AFA5260-A726-44B5-A59F-3163EF441419Q33967476-5EE21808-A463-4134-89E1-F6089F245DEBQ34170802-B72A403D-557D-4CF3-BA2A-5FF89B971625Q34488885-1A99E9D9-0725-48DB-88D8-4F9F924F90ABQ34630392-99455643-16AB-4F9C-9DC8-463D021E0977Q34749867-E3C68FA9-1AEB-4BE0-894F-337F68A92EF1Q34929161-8E11081D-A05E-45A6-8BE3-99228AA06435Q34982602-F2D98899-5BFC-489E-8B64-B1850B59D3A9Q35042668-3838C4C8-1C5E-4862-BA01-3479BE5F6DB1Q36296416-3B8F8BA7-007E-4B35-9B6E-2A5E9C1C74FCQ36369794-7B62671D-B0A8-41DF-8A9F-1B015CF941D5Q36401812-AE807B9B-A437-4CE5-9FBF-CC125A1BDCECQ36641756-09F91DE5-7732-4183-A92C-652D71158546Q36643654-C7E23B3B-F5B6-4728-B3E1-4476D2F1CC84Q36838928-AFB98CF7-8299-498B-B53B-236E24224796Q36871712-B0A17BA6-2523-4F06-B842-7710C2000991Q36969867-04478A02-969B-4E7A-8AC6-053A5D3DD0E4Q37213801-C9C0AF33-D30F-4D90-BC5E-DBF91387910AQ37269038-FB5C18E1-A502-4F4B-84B9-0A73A6EDC114Q37469791-2A8971BE-8170-4B42-A4FA-78AA269CD029Q37640613-E702D547-29EA-4F49-9DD7-9D54D2ED0DC3Q40445765-563EAC4F-14A4-49F4-8684-EB9B93A81662Q40457650-E6C0F45B-5EE9-487B-8148-5A78ADC69840Q40603185-896D6A93-4E9A-420C-A6EE-F7F8788E43FAQ40822480-AB029C2C-C731-4003-BA1F-F6D58A295609Q40881849-7355F9E4-1A59-45E6-9112-E41E9F2412A3Q41094556-6CF040A4-3D2D-4F14-9256-41BF9B351CD9Q41109872-FC871FCC-9159-4B55-B46F-D5383BE39C87Q41257903-847C19D8-FEA8-4472-8EFC-D5052E1099F1Q41884751-771470A7-DB20-49FC-A69A-EA756252CE50Q42127810-03DE153D-56E5-4261-91FD-4411A12273BD
P2860
Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Expression of high affinity in ...... wth in vitro by interleukin-4.
@ast
Expression of high affinity in ...... wth in vitro by interleukin-4.
@en
type
label
Expression of high affinity in ...... wth in vitro by interleukin-4.
@ast
Expression of high affinity in ...... wth in vitro by interleukin-4.
@en
prefLabel
Expression of high affinity in ...... wth in vitro by interleukin-4.
@ast
Expression of high affinity in ...... wth in vitro by interleukin-4.
@en
P2093
P2860
P356
P1476
Expression of high affinity in ...... wth in vitro by interleukin-4.
@en
P2093
P2860
P356
10.1172/JCI116205
P407
P577
1993-01-01T00:00:00Z